- Home
- NRO vs FBRX Comparison
NRO vs FBRX Comparison
Compare NRO & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRO
- FBRX
- Stock Information
- Founded
- NRO 2003
- FBRX N/A
- Country
- NRO United States
- FBRX United States
- Employees
- NRO N/A
- FBRX N/A
- Industry
- NRO Finance/Investors Services
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- NRO Finance
- FBRX Health Care
- Exchange
- NRO Nasdaq
- FBRX Nasdaq
- Market Cap
- NRO 156.7M
- FBRX 154.5M
- IPO Year
- NRO N/A
- FBRX N/A
- Fundamental
- Price
- NRO $3.21
- FBRX $11.57
- Analyst Decision
- NRO
- FBRX Strong Buy
- Analyst Count
- NRO 0
- FBRX 2
- Target Price
- NRO N/A
- FBRX $61.00
- AVG Volume (30 Days)
- NRO 239.4K
- FBRX 53.8K
- Earning Date
- NRO 01-01-0001
- FBRX 08-14-2025
- Dividend Yield
- NRO 11.41%
- FBRX N/A
- EPS Growth
- NRO N/A
- FBRX N/A
- EPS
- NRO N/A
- FBRX N/A
- Revenue
- NRO N/A
- FBRX N/A
- Revenue This Year
- NRO N/A
- FBRX N/A
- Revenue Next Year
- NRO N/A
- FBRX N/A
- P/E Ratio
- NRO N/A
- FBRX N/A
- Revenue Growth
- NRO N/A
- FBRX N/A
- 52 Week Low
- NRO $2.51
- FBRX $4.11
- 52 Week High
- NRO $3.45
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- NRO 46.52
- FBRX 57.91
- Support Level
- NRO $3.19
- FBRX $9.91
- Resistance Level
- NRO $3.27
- FBRX $11.26
- Average True Range (ATR)
- NRO 0.04
- FBRX 0.84
- MACD
- NRO 0.00
- FBRX 0.15
- Stochastic Oscillator
- NRO 28.75
- FBRX 88.53
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).